In this project, the IMProGlyco team are developing an exciting new strategy to engineer glycans in mammalian cells. This approach will be used to tailor the production of individual proteins and cell lines, changing the pattern of observed glycoforms to modulate their activity and hence pharmacological properties. For further details, refer to https://improglyco.science/
Glycopar (EU FP7 Marie Curie Initial Training Network)
Research Database
For further details on Prof. Wilson's research, publications and experience, please click here to view his record in the university's research databank or his ORCID entry.